Clinical Trial Update: Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations [NA]

View source ↗

Summary

Clinical trial update indicating completion and posting of results for a study on local therapies in oligometastatic non-small cell lung cancer with sensitizing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Oligometastatic Lung Adenocarcinoma | NA | Status: COMPLETED | Results posted: 2018-04-20